2023
DOI: 10.3389/fphar.2023.1168972
|View full text |Cite
|
Sign up to set email alerts
|

Editorial: Biological drugs and biosimilars in autoimmune diseases

Abstract: The usage of biological drugs in autoimmune diseases treatment has significantly changed the clinical disease course especially for patients with particularly complicated or poor response to the treatment, demonstrating the ability to inhibit disease progression. Therefore, nowadays, biologics represent an increasing proportion of total pharmaceutical expenses despite differences in standard of routine care and high prices (Reardon, 2020). The articles presented in the Research Topic highlight the broad area o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 3 publications
(4 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?